Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1730 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed494    
    Printed26    
    Emailed1    
    PDF Downloaded74    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 2000  |  Volume : 42  |  Issue : 1  |  Page : 101-103

Risperidone-Induced Neuroleptic Malignant Syndrome : A Case Report


1 Junior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India
2 Senior Resident, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India
3 Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029, India

Correspondence Address:
B N Gangadhar
Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore-560029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21407918

Rights and PermissionsRights and Permissions

A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response of the symptom clusters are discussed.



[PDF]*

        

Print this article         Email this article